TABLE 2.
Bacterial strains used to characterize the lysis spectra of the phages and respective EOP.
| Bacteria | Phage group | References | ||
| Peduovirus vB_EcoM-12474V | Tequintavirus vB_EcoS-26175V | Tunavirinae vB_EcoS-2004IV | ||
| Escherichia coli DSM 12242 | 1.000 ± 0.000 | 1.000 ± 0.000 | 1.000 ± 0.000 | DSMZ |
| Escherichia coli ATCC 11303 | – | 0.228 ± 0.048 | – | ATCC |
| Escherichia coli W3110 (ATCC 27325) | – | 0.840 ± 0.260 | 0.812 ± 0.080 | ATCC |
| Escherichia coli JM109 (DSM 3423) | – | 0.011 ± 0.004 | 0.145 ± 0.030 | DSMZ |
| Escherichia coli DH5α (DSM 6897) | – | 0.195 ± 0.055 | – | DSMZ |
| Escherichia coli MC1061 (ATCC 53338) | 0.283 ± 0.150 | 0.541 ± 0.287 | 0.509 ± 0.034 | ATCC |
| Klebsiella pneumoniae sub. pneumoniae ATCC 13883 | – | – | – | ATCC |
| Yersinia enterocolitica sub. palearctica DSM 11502 | – | – | – | DSMZ |
| Salmonella enterica sub. enterica ATCC 14028 | – | – | – | ATCC |
| Salmonella typhimurium DT104 isolate H3380 | – | – | – | Clinical (Briggs and Fratamico, 1999) |
| Escherichia coli isolated from samples (n = 18) | – | – | – | This study |
| Escherichia coli isolates (n = 20) | – | – | – | Clinical |
| Escherichia coli isolate P3 | – | – | – | Clinical |
| Escherichia coli isolate P4 | – | – | – | Clinical |
| Escherichia coli isolate P5 | – | – | – | Clinical |
| Klebsiella pneumoniae isolate P6 | – | – | – | Clinical |
| Klebsiella pneumoniae isolate P7 | – | – | – | Clinical |
| Klebsiella pneumoniae isolate P8 | – | – | – | Clinical |
| Klebsiella oxytoca isolate P10 | – | – | – | Clinical |
These consisted in E. coli laboratory strains used in phage enumeration and isolation, additional Enterobacteriaceae species, E. coli isolated from the biological fluid samples and other bacterial isolates collected from patients and outpatients in this clinical setting.